China - Synovac will make 600 million doses of Corona vaccine

A good news is coming from China that Synovac has announced that it plans to double its annual production capacity by the end of this year for Corona's vaccine. The company aims to produce 600 million doses of the vaccine. The company also says that it also plans to acquire a $ 500 million investment to boost its efforts to develop the Corona vaccine. However, the final phase of this vaccine is undergoing trials.

According to media reports, the final phase of at least five of Corona's Chinese vaccine trials is underway in more than 12 countries. It also includes the Synovac vaccine. The final phase of this vaccine is currently undergoing clinical trials in Brazil, Turkey and Indonesia.

According to reports, pharmaceutical company Sino Biopharmaceutical Limited has bought a 15 percent stake in Synovac for an investment of $ 500 million. Synovac CEO Yin Weidong says the funding will help the company improve its vaccine sales capabilities, expand into Asia markets, develop and use new technologies, and tackle this global epidemic.

Although according to reports, the vaccine developed by Chinese company Sinopharm has been given to about 1 million people, but none have seen any serious side-effects. Deputy Deputy Prime Minister Sun Chunlan said that we should now be ready to produce the vaccine on a large scale.